SGYP - poorgradstudent - I'm wondering why you said Linzess might have a slight edge in efficacy? Did you compare Phase 3 trial results? I am asking because I tried to do so but was unable to conceive an intelligent comparison. Thanks for the input. Andy
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.